CPT1A and breast carcinoma: By comparison, CPT1A expression was only upregulated in ~2% (2/107) basal-like breast cancer samples in the TCGA dataset, and showed lower overall expression in the 105 unaltered cases compared to ER+ samples (9.99 ± 0.80), similar to the expression levels seen in breast cancer cell lines (Fig. 4a).